Distinguished in B-Cell Lymphoma

Yuankai K. Shi

Chinese Academy Of Medical Sciences And Peking Union Medical College, Beijing Key Laboratory Of Clinical Study On Anticancer Molecular Targeted Drugs, Chaoyang District, 
Beijing, CN 
Distinguished in B-Cell Lymphoma
Chinese Academy Of Medical Sciences And Peking Union Medical College, Beijing Key Laboratory Of Clinical Study On Anticancer Molecular Targeted Drugs, Chaoyang District, 
Beijing, CN 
OverviewLocationsClinical Research

Overview

Yuankai Shi practices in Beijing, China. Shi is rated as a Distinguished expert by MediFind in the treatment of B-Cell Lymphoma. Their top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Lung Cancer, Tissue Biopsy, and Small Bowel Resection.

Their clinical research consists of co-authoring 470 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 58 articles in the study of B-Cell Lymphoma.

Locations

Chinese Academy Of Medical Sciences And Peking Union Medical College, Beijing Key Laboratory Of Clinical Study On Anticancer Molecular Targeted Drugs, Chaoyang District, Beijing, China
Other Locations
Chaigoubu, 223000, China
Shanghai, 201102, China
Dongyang, 322100, China
Zhongshan, 200030, China
Chinese Academy Of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory Of Clinical Study On Anticancer Molecular Targeted Drugs, Beijing, Chaoyang, China
Fuzhou, 350014, China
Hangzhou, 310000, China
Changzhou, 213200, China
Liangxiang, China
Nantong, 226001, China
Nanjing, 210002, China
Tianjin, China
Wuxi, China
Minhang, 201199, China
ENT Head And Neck Surgery 263 Clinical Department Of General Army Hospital, 101149, China
Suzhou, China
Pudong, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

470 Total Publications

Bendamustine combined with anti-CD20 monoclonal antibody in the first-line treatment of older patients with indolent B-cell non-Hodgkin lymphoma: a multicenter retrospective study
Bendamustine combined with anti-CD20 monoclonal antibody in the first-line treatment of older patients with indolent B-cell non-Hodgkin lymphoma: a multicenter retrospective study
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: October 27, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Shi's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 7 Advanced Conditions
View All 55 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile